Blog: Blog2

GPCR News

Jul 31, 20221 min read

Karuna Therapeutics Announces Positive Results from Phase 3 EMERGENT-2 Trial of KarXT in...

August 2022 Karuna Therapeutics Announces Positive Results from Phase 3 EMERGENT-2 Trial of KarXT in Schizophrenia "BOSTON--(BUSINESS...

Mar 31, 20221 min read

Modulation of Striatal Adenosinergic Function by HTL0041178, a Selective GPR52 Agonist

April 2022 "By Cliona MacSweeney | Apr 20, 2022 Cliona MacSweeney, a project director in our Translational Medicine department, recently...

Mar 31, 20221 min read

Addex Expands Pipeline With Selective M4 Positive Allosteric Modulator Program For The Treatment ...

April 2022 Addex Expands Pipeline With Selective M4 Positive Allosteric Modulator Program For The Treatment Of Schizophrenia & Other...